Search Results
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms
R/R HER2+ mBC: Interpreting Findings From the NALA Trial
HER2CLIMB and NALA Trials: R/R HER2+ mBC
KATHERINE trial updates for HER2-positive breast cancer
Debu Tripathy, MD, elaborates on the SOPHIA trial in HER+ metastatic breast cancer
HER2CLIMB and NALA Trials: R/R HER2+ mBC
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive MBC after prior ant...
Margetuximab Plus Chemotherapy in HER2+ Breast Cancer
Medical update: HER2-Positive and triple-positive metastatic breast cancer
Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast Cancer
#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer
